These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


714 related items for PubMed ID: 19156591

  • 1. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
    Hilgard P, Müller S, Hamami M, Sauerwein WS, Haberkorn U, Gerken G, Antoch G.
    Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
    [Abstract] [Full Text] [Related]

  • 2. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
    Antoch G, Mueller SP, Hamami M, Heusner TA, Ertle J, Hilgard P, Forsting M, Bockisch A.
    Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
    [Abstract] [Full Text] [Related]

  • 3. Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.
    Herzer K, Müller S, Antoch G, Hilgard P.
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):287-98. PubMed ID: 21769078
    [Abstract] [Full Text] [Related]

  • 4. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
    Cao X, He N, Sun J, Tan J, Zhang C, Yang J, Lu T, Li J.
    Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
    [Abstract] [Full Text] [Related]

  • 5. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
    Welsh JS, Kennedy AS, Thomadsen B.
    Int J Radiat Oncol Biol Phys; 2006 May; 66(2 Suppl):S62-73. PubMed ID: 16979443
    [Abstract] [Full Text] [Related]

  • 6. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
    Raoul JL, Boucher E, Roland V, Garin E.
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
    [Abstract] [Full Text] [Related]

  • 7. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
    Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D.
    Int J Radiat Oncol Biol Phys; 2007 May 01; 68(1):13-23. PubMed ID: 17448867
    [Abstract] [Full Text] [Related]

  • 8. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.
    Lau WY, Kennedy AS, Kim YH, Lai HK, Lee RC, Leung TW, Liu CS, Salem R, Sangro B, Shuter B, Wang SC.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):401-7. PubMed ID: 20950954
    [Abstract] [Full Text] [Related]

  • 9. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
    Sangro B, Bilbao JI, Boan J, Martinez-Cuesta A, Benito A, Rodriguez J, Panizo A, Gil B, Inarrairaegui M, Herrero I, Quiroga J, Prieto J.
    Int J Radiat Oncol Biol Phys; 2006 Nov 01; 66(3):792-800. PubMed ID: 16904840
    [Abstract] [Full Text] [Related]

  • 10. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK, Omary RA, Gates V, Mounajjed T, Larson AC, Barakat O, Sato KT, Mulcahy M, Gordon S, Lewandowski RJ, Salem R.
    J Vasc Interv Radiol; 2005 Aug 01; 16(8):1085-91. PubMed ID: 16105920
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432.
    Ho S, Lau WY, Leung WT.
    Chin Med J (Engl); 2001 Apr 01; 114(4):433-4. PubMed ID: 11780473
    [No Abstract] [Full Text] [Related]

  • 13. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.
    Salem R, Hunter RD.
    Int J Radiat Oncol Biol Phys; 2006 Apr 01; 66(2 Suppl):S83-8. PubMed ID: 16979447
    [Abstract] [Full Text] [Related]

  • 14. Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.
    Liepe K, Brogsitter C, Leonhard J, Wunderlich G, Hliscs R, Pinkert J, Folprecht G, Kotzerke J.
    Jpn J Clin Oncol; 2007 Dec 01; 37(12):942-50. PubMed ID: 18094017
    [Abstract] [Full Text] [Related]

  • 15. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
    Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1552-63. PubMed ID: 15590187
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.
    Chiesa C, Maccauro M, Romito R, Spreafico C, Pellizzari S, Negri A, Sposito C, Morosi C, Civelli E, Lanocita R, Camerini T, Bampo C, Bhoori S, Seregni E, Marchianò A, Mazzaferro V, Bombardieri E.
    Q J Nucl Med Mol Imaging; 2011 Apr 01; 55(2):168-97. PubMed ID: 21386789
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.